Related references
Note: Only part of the references are listed.Immunosenescence and HIV
Steven G. Deeks et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
Giovanni Guaraldi et al.
CLINICAL INFECTIOUS DISEASES (2011)
Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study
K. Petoumenos et al.
HIV MEDICINE (2011)
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
Signe Westring Worm et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction
C. A. Sabin et al.
CLINICAL INFECTIOUS DISEASES (2008)
Class of antiretroviral drugs and the risk of myocardial infarction
Nina Friis-Moller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Combination antiretroviral therapy and the risk of myocardial infarction
N Friis-Moller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Gilbert syndrome and ischemic heart disease:: a protective effect of elevated bilirubin levels
L Vítek et al.
ATHEROSCLEROSIS (2002)
Share Paper
